Millie
your market intelligence analyst
Search Results
6 results
Your search is now limited to «Tuberculosis» expert search.
European Respiratory Journal 02/14/2020 06:10
Bedaquiline is a highly effective drug for tuberculosis (TB) and is an important part of current regimens for drug-resistant TB. Bedaquiline resistance is rarely tested in operational settings. In a prospective cohort of 292 patients with drug-resistant TB and HIV starting bedaquiline in KwaZulu-Natal, South Africa, we whole genome sequenced isolates from 92 baseline culture positive patients. Five patients were infected with strains harbouring mutations associated with bedaquiline resistance, and an additional five acquired resistance mutations during treatment. Among the baseline culture positive patients, those with baseline or acquired resistance mutations had substantially worse clinical outcomes compared to patients without. Given the.

Financial Services

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Information Technologies

Job Titles

Legal and Regulatory

Political Entities

Sources

Strategic Scenarios

Trends

Hints:

  • Actions
    • Bookmark and Share: Allows you to Bookmark the page for easy future retrieval and sharing with colleagues
    • Email: Opens a pop-up window where you can write a message to the recipient of the email
    • Copy URL: Copies the URL of the requested document for pasting in an email or other document
    • Previous Versions: Only shown if essentially the same document has been republished
  • Saved Searches and Alerts
    • Save your search for later viewing & updates by clicking the blue "Save" button to the right of the search box. 

Click here for more info on Search Results.